Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.

PubWeight™: 3.27‹?› | Rank: Top 1%

🔗 View Article (PMC 3344989)

Published in Proc Natl Acad Sci U S A on April 12, 2012

Authors

Keiichi Kodama1, Momoko Horikoshi, Kyoko Toda, Satoru Yamada, Kazuo Hara, Junichiro Irie, Marina Sirota, Alexander A Morgan, Rong Chen, Hiroshi Ohtsu, Shiro Maeda, Takashi Kadowaki, Atul J Butte

Author Affiliations

1: Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Articles citing this

Gene data to hit milestone. Nature (2012) 2.27

Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med (2012) 1.53

Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Diabetes (2013) 1.12

Retinoic acid-related orphan receptors α and γ: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity. Front Endocrinol (Lausanne) (2013) 1.06

Systems biology: personalized medicine for the future? Curr Opin Pharmacol (2012) 1.04

CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One (2013) 0.92

The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol (2015) 0.91

Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice. PLoS One (2014) 0.90

Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases. Curr Cardiovasc Risk Rep (2012) 0.89

Systems biology approach reveals genome to phenome correlation in type 2 diabetes. PLoS One (2013) 0.89

Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep (2015) 0.88

Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice. Diabetes (2014) 0.87

Human skeletal myotubes display a cell-autonomous circadian clock implicated in basal myokine secretion. Mol Metab (2015) 0.85

Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther (2016) 0.84

The extracellular matrix and insulin resistance. Trends Endocrinol Metab (2015) 0.84

Meta-analysis of molecular response of kidney to ischemia reperfusion injury for the identification of new candidate genes. BMC Nephrol (2013) 0.82

Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev (2015) 0.81

Identifying candidate genes for Type 2 Diabetes Mellitus and obesity through gene expression profiling in multiple tissues or cells. J Diabetes Res (2013) 0.81

Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes. PLoS One (2015) 0.80

Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance. Mediators Inflamm (2015) 0.80

Association of genes with physiological functions by comparative analysis of pooled expression microarray data. Physiol Genomics (2012) 0.80

Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside. Am J Reprod Immunol (2013) 0.79

Molecular and genetic inflammation networks in major human diseases. Mol Biosyst (2016) 0.79

Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab (2015) 0.79

Adipose extracellular matrix remodelling in obesity and insulin resistance. Biochem Pharmacol (2016) 0.78

Identification of new biomarkers for Acute Respiratory Distress Syndrome by expression-based genome-wide association study. BMC Pulm Med (2015) 0.78

Treatment of hyaluronan accumulation ameliorates high-fat diet-induced insulin resistance in mice. Diabetes (2013) 0.78

Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studies. Sci Rep (2015) 0.77

A genomic signature approach to rescue ΔF508-cystic fibrosis transmembrane conductance regulator biosynthesis and function. Am J Respir Cell Mol Biol (2014) 0.77

Transcriptome analysis of hen preadipocytes treated with an adipogenic cocktail (DMIOA) with or without 20(S)-hydroxylcholesterol. BMC Genomics (2015) 0.76

The onset of type 2 diabetes: proposal for a multi-scale model. JMIR Res Protoc (2013) 0.76

Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease. Mol Med (2016) 0.76

A novel gene network analysis in liver tissues of diabetic rats in response to resistant starch treatment. Springerplus (2015) 0.76

Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy. J Cell Mol Med (2016) 0.76

Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment. Arthritis Res Ther (2015) 0.76

Pancreatic Islet Protein Complexes and Their Dysregulation in Type 2 Diabetes. Front Genet (2017) 0.75

Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes. Diabetes (2016) 0.75

Pharmacogenomics of cardiovascular complications in diabetes and obesity. Recent Pat Biotechnol (2014) 0.75

Differential gene expression in disease: a comparison between high-throughput studies and the literature. BMC Med Genomics (2017) 0.75

Deciphering the regulation of porcine genes influencing growth, fatness and yield-related traits through genetical genomics. Mamm Genome (2016) 0.75

The Munich MIDY Pig Biobank - A unique resource for studying organ crosstalk in diabetes. Mol Metab (2017) 0.75

Articles cited by this

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95

Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16

A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature (2007) 35.08

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Inflammation and metabolic disorders. Nature (2006) 33.33

Inflammation and insulin resistance. J Clin Invest (2006) 18.76

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Variations in DNA elucidate molecular networks that cause disease. Nature (2008) 12.04

An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet (2005) 11.40

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28

Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig (2010) 10.98

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet (2008) 9.39

SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet (2008) 8.63

Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol (2005) 7.46

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58

Diet-induced type II diabetes in C57BL/6J mice. Diabetes (1988) 6.26

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet (1999) 4.48

Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol (2000) 4.02

Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet (2010) 3.75

A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet (2010) 2.81

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73

Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48

AILUN: reannotating gene expression data automatically. Nat Methods (2007) 2.47

An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet (2010) 2.43

Show me the data! Nat Genet (2001) 2.17

Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science (2004) 2.15

Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med (1995) 2.05

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.98

Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91

Identification of hypertension-related genes through an integrated genomic-transcriptomic approach. Circ Res (2005) 1.67

The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53

Questioning standardization in science. Nat Methods (2009) 1.40

A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest (2003) 1.36

Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology (2011) 1.09

CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood (2008) 1.04

Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross. PLoS One (2010) 1.04

Articles by these authors

Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA (2009) 11.52

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28

Clinical assessment incorporating a personal genome. Lancet (2010) 10.18

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet (2008) 9.39

Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol (2010) 8.69

SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet (2008) 8.63

Performance comparison of exome DNA sequencing technologies. Nat Biotechnol (2011) 7.11

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08

Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07

Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 6.38

Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics (2009) 6.31

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med (2007) 5.89

Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79

Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med (2011) 5.77

Evaluation of text data mining for database curation: lessons learned from the KDD Challenge Cup. Bioinformatics (2003) 5.77

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem (2006) 5.57

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest (2004) 5.29

Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem (2002) 4.79

Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50

An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One (2010) 4.42

Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res (2007) 4.23

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem (2002) 4.16

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature (2010) 4.12

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem (2003) 4.08

Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes (2007) 3.87

Rutabaga by any other name: extracting biological names. J Biomed Inform (2002) 3.74

A two-step method for marking polypectomy sites in the colon and rectum. Gastrointest Endosc (2003) 3.63

FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell (2009) 3.54

Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab (2005) 3.49

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48

Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab (2007) 3.43

PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol (2002) 3.37

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract (2002) 3.30

Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes (2007) 3.24

Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol (2010) 3.23

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20

Data preparation and interannotator agreement: BioCreAtIvE task 1B. BMC Bioinformatics (2005) 3.19

Protein-Protein Docking Benchmark 2.0: an update. Proteins (2005) 3.13

Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes (2002) 3.04

Cardiovascular disease and risk factors in Asia: a selected review. Circulation (2008) 3.00

Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92

Finding disease-related genomic experiments within an international repository: first steps in translational bioinformatics. AMIA Annu Symp Proc (2006) 2.88

Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics (2005) 2.83

Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest (2007) 2.81

A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet (2010) 2.81

In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest (2008) 2.78

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care (2006) 2.77

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature (2013) 2.74

Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol (2008) 2.74

Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet (2002) 2.72

Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70

Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol (2005) 2.68

Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors. Gastrointest Endosc (2010) 2.67

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell (2008) 2.67

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology (2003) 2.65

Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med (2002) 2.61

Computerized recruiting for clinical trials in real time. Ann Emerg Med (2003) 2.59

Integrating statistical pair potentials into protein complex prediction. Proteins (2007) 2.53

Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform (2011) 2.52

Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 2.51

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood (2009) 2.50

Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem (2007) 2.50

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50